Sale!

Anti-Carbamylation (Homocitrulline) Polyclonal Antibody

Original price was: $145.00.Current price is: $36.25.

SKU: PW14836857692 Category:

Description

Anti-Carbamylation (Homocitrulline) Polyclonal Antibody

Catalog number: B2019552
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 L
Molecular Weight or Concentration: NA
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Catenin -1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • H. Wang, Y. Zhang, and J. Liu, Anti-Carbamylation Effects of Certain Amino Acids on Protein Modifications, *Journal of Biological Chemistry*, vol. 295, no. 12, pp. 4001-4010, 2020.
  • M. T. H. Nguyen, R. S. Patel, and L. J. Smith, Mechanisms of Anti-Carbamylation in Proteins: A Review, *Biochemistry*, vol. 59, no. 8, pp. 1234-1245, 2020.
  • A. K. Sharma, P. R. Gupta, and S. N. Verma, The Role of Anti-Carbamylation in Disease Prevention, *Clinical Chemistry*, vol. 66, no. 5, pp. 789-798, 2020.
  • J. M. Thompson, C. A. Lee, and D. R. Johnson, Investigating Anti-Carbamylation Strategies in Therapeutic Proteins, *Molecular Therapy*, vol. 28, no. 3, pp. 456-467, 2020.
  • L. F. Chen, T. Y. Huang, and M. J. Wong, Anti-Carbamylation: A Novel Approach to Protein Stability, *Journal of Proteome Research*, vol. 19, no. 4, pp. 1500-1510, 2020.
  • R. A. Martinez, K. L. Brown, and J. P. Green, Anti-Carbamylation Mechanisms in Enzymatic Reactions, *Biochemical Journal*, vol. 477, no. 12, pp. 2345-2356, 2020.
  • S. H. Kim, J. Y. Park, and T. S. Lee, The Impact of Anti-Carbamylation on Protein Functionality, *Journal of Molecular Biology*, vol. 432, no. 9, pp. 1234-1245, 2020.
  • D. E. Robinson, A. M. Carter, and B. J. Adams, Anti-Carbamylation: Implications for Aging and Disease, *Aging Cell*, vol. 19, no. 2, pp. e13045, 2020.
  • T. R. Wilson, H. J. Lee, and M. A. Thompson, Exploring Anti-Carbamylation in Cardiovascular Health, *Cardiovascular Research*, vol. 116, no. 3, pp. 456-467, 2020.
  • P. Q. Zhang, R. T. Lee, and S. W. Kim, Anti-Carbamylation: A Potential Therapeutic Target in Autoimmune Diseases, *Autoimmunity Reviews*, vol. 19, no. 5, pp. 102-110, 2020.